Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

AZ and Merck & Co get FDA breast cancer nod for Lynparza

It becomes the first PARP inhibitor to be approved outside ovarian cancer

Lilly bolsters its oncology team

Kimberly Blackwell is appointed VP early phase development, immuno-oncology

Antabio bolsters leadership team

The French biopharma appoints four new executives

- PMLiVE

The power of pharma businesses to drive social change

The importance of CSR programmes

Through the Looking Glass

Non-traditional innovation

- PMLiVE

How to measure marketing success: profit vs ROI

Measuring marketing activity is proving to be a major challenge in pharma. Here, Senior Consultant Paul Townley-Jones explores the meaning of success and gives his tips for measuring efficiency and...

Blue Latitude Health

Roche Basel Switzerland

Roche’s Ocrevus is first primary progressive MS drug in EU

Analysts predict the drug could be a $3bn product by 2021

- PMLiVE

FDA panel rejects Aradigm/Grifols’ inhaled antibiotic

Further evidence is required to warrant approval according to the US regulator

- PMLiVE

Ferring agrees Chinese reproductive medicine research deal

Work with the Chinese Academy of Sciences on the long-term project

- PMLiVE

Healthcare Communications agency F/NE joins GLOBALHealthPR’s network

The South-African agency has a presence in over 40 other countries

- PMLiVE

Pfizer’s Elizabeth Barrett joins Novartis as its oncology head

She succeeds Bruno Strigini who retires

Four ways technology will make your exhibition stand more successful

Apex Events and Exhibitions

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links